Structural determinants of substrates and inhibitors: Probing glutamate transporters with 2,4-methanopyrrolidine-2,4-dicarboxylate

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 21, 1998, Pages 3101-3106

  Esslinger, C Sean ^a   Koch, Hans P ^a   Kavanaugh, Michael P ^b   Philips, Dean P ^c   Chamberlin, A Richard ^c   Thompson, Charles M ^a   Bridges, Richard J ^a  

^a UNIVERSITY OF MONTANA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 METHANOPYRROLIDINE 2,4 DICARBOXYLATE; GLUTAMIC ACID; LEVO ANTIENDO (3,4 METHANOPYRROLIDINE)DICARBOXYLATE; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ARTICLE; CONFORMATIONAL TRANSITION; DRUG CONFORMATION; DRUG EFFECT; DRUG SYNTHESIS; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; STRUCTURE ACTIVITY RELATION;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; DICARBOXYLIC ACIDS; GLUTAMIC ACID; MALE; MOLECULAR CONFORMATION; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0005761614     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00560-5     Document Type: Article

References (32)

1. 1. (a) Cotman, C. W.; Kahle, S. J.; Miller, S. E.; Ulas, J.; Bridges, R. J. In Psychopharmacology: The Fourth Generation of Progress; Bloom, F. E.; Kupfer, D. J., Eds.; Raven: New York, 1995; p 75.
2. (b) Monaghan, D. T.; Bridges, R. J.; Cotman, C. W. Ann. Rev. Pharmacol. Toxicol. 1989, 29, 365.
3. 2. (a) Rothman, S. M.; Olney, J. W. Trends Neurosci. 1995, 18, 57.
4. (b) Meldrum B.; Garthwaite, J. TIPS. 1990, 11, 379.
5. (c) Choi, D. W. Neuron 1988, 1623.
6. (d) Choi, D. W. J. Neurosci. 1990, 10, 2493.
7. (e) Bridges, R. J.; Geddes, J.; Monaghan, D. T.; Cotman, C. W. In Excitatory Amino Acids in Health and Disease; Lodge, D., Ed.; John Wiley and Sons: New York, 1988; p 321.
8. 3. Takahashi, M.; Biliups, B.; Rossi, D.; Sarantis, M.; Hamann, M.; Atwell, D. J. Expt. Biol. 1997, 200, 401.
9. 4. (a) Kanai, Y.; Hediger, M. A. Nature (London) 1992, 360, 467.
10. (b) Pines, G.; Danbolt, N. C.; Bjoras, M.; Bendahan, A.; Eide, L.; Koepsell, H.; Storm-Mathisen, J.; Kanner, B. I. Nature (London) 1992, 360, 464.
11. (c) Storck, T.; Schulte, S.; Hofmann, K.; Stoffel, W. Proc. Nat. Acad. Sci. U.S.A. 1992, 89, 10955.
12. 5 Arriza, J. L.; Fairman, W. A.; Wadiche, J. I.; Murdoch, G.H.; Kavanaugh, M. P.; Amara, S. G. J. Neurosci. 1994, 14, 5559.
13. 6. (a) Chamberlin, A. R.; Bridges, R. J. In Drug Design for Neuroscience; Kozikowski, A., Ed.; Raven: New York, 1993, p 231.
14. (b) Sonnenberg, J.; Koch, H.; Bradbury, F.; Dauenhauer, D.; Bridges, R. J.; Chambrlin, A. R. Bioorg. Med. Chem. Lett. 1996, 6, 1607.
15. 7. (a) Bigge, C. F.; Johnson, G.; Ortwine, D. F.; Drummond, J. T.; Retz, D. M.; Brahce, L. J.; Coughenour, L. L.; Marcoux, F. W.; Probert, A. W. Jr. J. Med. Chem. 1992, 35, 1371.
16. (c) Hutchison, A. T.; Williams, M.; Angst, C.; de Jesus, R.; Blanchard, L.; Jackson, R. H.; Wilusz, E. J.; Murphy, D. E.; Bernard, P. S.; Schneider, J.; Campbell, T.; Guida, W.; Sills, M. A. J. Med. Chem. 1989, 32, 2171.
17. (d) Ortwine, D. F.; Malone, T. C.; Bigge, C. F.; Drummond, J. T.; Humblet, C.; Johnson, G.; Pinter, G. W. J. Med. Chem. 1992, 35, 1345.
18. (e) Watkins, J. C.; Krogsgaard-Larsen, P.; Honore, T. TIPS. 1990, 11, 25.
19. 8. (a) Bridges, R. J.; Stanley, M. S.; Anderson, M. W.; Cotman, C. W.; Chamberlin, A. R. J. Med. Chem. 1991, 34 717.
20. (b) Bridges, R. J.; Shim, S. N.; Chamberlin, A. R. Soc. Neurosci. Abs. 1991, 17, 393.
21. 9. Liel, E.L.; Wilen, S.H. In Stereochemistry of Organic Compounds; J. Wiley Interscience; New York, 1994, p 597.
22. 10. Bridges, R. J.; Lovering, F. E.; Koch, H.; Cotman, C. W.; Chamberlin, A. R. Neurosci. Lett. 1994, 174, 193.
23. 11. (a) Hughes, P.; Martin, M.; Clardy, J. Tetrahedron Lett. 1980, 21, 4579.
24. (b) Pirrung, M. C. Tetrahedron Lett. 1980, 27, 4577.
25. 12. Villieran, J.; Rambaud, M. Synth. Comm. 1982, 924.
26. 13. (a) Fisher, F.; Raske, V. Chem. Ber. 1907, 40, 3717.
27. (b) Painter, E. P. J. Am. Chem. Soc. 1947, 69, 229.
28. 14. Arunlakshana, O.; Schild, H. O. Br. J. Pharmacol. 1959, 14, 48.
29. 15. Booth, R. F. G.; Clark, J. B. Biochem. J. 1978, 176, 365.
30. 16. Kuhar, M. J.; Zarbin, M. J. Neurochem. 1978, 31, 251.
31. 17. Smith, P. K.; Krohn, R. I.; Hermanson, G. T.; Mallia, A. K.; Gartner, F. H.; Provenzano, M. D.; Fujimoto, E. K.; Goeke, N. M.; Olson, B. J.; Klenk, D. C. Anal. Biochem. 1985, 150, 76.
32. 18. Ham, N.S. In Molecular and Quantum Pharamacology, Reidel, D.; Ed.; Holland; Dordecht, 1974, p 261.